N-Boc-D-Cyclohexylglycinol Bulk Handling: Winter Agglomeration Fix

Cold-Chain Logistics for N-Boc-D-cyclohexylglycinol: Mitigating Winter Agglomeration in Bulk Shipments

Procurement managers sourcing N-Boc-D-cyclohexylglycinol (CAS 188348-00-7) for solid-phase peptide synthesis (SPPS) often encounter a recurring winter logistics challenge: agglomeration of the fine crystalline powder into hard lumps during transit. This phenomenon, observed with the chiral intermediate tert-butyl N-[(1R)-1-cyclohexyl-2-hydroxyethyl]carbamate, is not a chemical degradation but a physical transformation driven by sub-zero temperatures and mechanical vibration. As a drop-in replacement for identical chemical entities from original innovators, our product matches the critical quality attributes—enantiomeric purity ≥99.0%, single impurity ≤0.5%—while offering superior supply chain resilience. The agglomeration issue, if unaddressed, can disrupt automated resin loading in SPPS, leading to inconsistent coupling efficiencies and costly production delays. Understanding the root cause and implementing preventive measures is essential for maintaining seamless manufacturing workflows.

From field experience, the agglomeration is exacerbated by residual solvent traces and the compound's inherent hygroscopicity. Even at standard purity levels, trace moisture can act as a binder at low temperatures, fusing particles together. This is particularly problematic when the material is shipped in non-climate-controlled containers across northern routes. Our technical team has documented that the Boc-D-Chg-ol powder, when subjected to freeze-thaw cycles, can form aggregates that resist gentle mechanical agitation. However, these aggregates are reversible with proper re-slurrying techniques, as detailed later. For procurement planning, it is critical to specify cold-chain logistics or insulated packaging during winter months to minimize thermal stress. We recommend that bulk orders of N-Boc-D-cyclohexylglycinol be shipped with temperature loggers to monitor exposure, ensuring that the material remains within the optimal storage range of 2–8°C, as indicated on the batch-specific COA.

Packaging Specifications: Standard bulk packaging includes 25kg fiber drums with inner double-layer LDPE liners and desiccant bags. For moisture-sensitive applications, we offer vacuum-sealed aluminum foil bags inside the drum. IBC totes (500kg) are available for large-scale campaigns, with nitrogen blanketing upon request. All packaging complies with UN/DOT regulations for non-hazardous chemical transport. Storage recommendation: Keep containers tightly closed in a dry, cool (2–8°C) area, protected from light and moisture.

For those integrating this amino alcohol derivative into macrocyclic peptidomimetics, the physical state of the starting material directly impacts the efficiency of on-resin cyclization. In our related article, we discuss how preventing premature Boc cleavage is critical for macrocyclic peptidomimetics, where agglomerated starting material can lead to inaccurate weighing and off-ratio stoichiometry. Similarly, for catalyst-sensitive processes, eliminating catalyst poisoning starts with high-purity, free-flowing N-Boc-D-cyclohexylglycinol. By addressing the physical form upfront, you safeguard downstream chemistry.

Impact of Sub-Zero Transit on Fine Crystalline Morphology and Solid-Phase Peptide Synthesis Resin Loading Efficiency

The crystalline morphology of N-Boc-D-cyclohexylglycinol is a critical quality attribute often overlooked in standard specifications. Our manufacturing process yields a consistent, free-flowing powder with a defined particle size distribution (typically D90 < 150 µm). However, exposure to temperatures below -10°C during transit can induce a phase change in the amorphous content, leading to sintering of particles. This is not a melting point depression but a solid-state transformation where surface energy minimization drives particle fusion. The result is a caked mass that resists pouring and requires mechanical force to break apart, introducing the risk of contamination and operator exposure.

In solid-phase peptide synthesis, the loading of the first amino acid onto the resin is a kinetically controlled step that demands precise stoichiometry. When tert-butyl 1-cyclohexyl-2-hydroxyethylcarbamate is used as a building block, any deviation in the weighed amount due to clumping can lead to incomplete loading or excess reagent consumption. For large-scale peptide manufacturing, this translates to batch-to-batch variability and increased cost of goods. Our field engineers have observed that even after mechanical grinding, the altered particle size distribution can affect dissolution rates in DMF or DCM, potentially causing localized hot spots during activation. To mitigate this, we recommend that quality control labs perform a flowability test (e.g., angle of repose) upon receipt of winter shipments and compare against the reference standard. If agglomeration is detected, the re-slurrying protocol described in the next section should be implemented before use in GMP production.

Another non-standard parameter to monitor is the color of the powder. While the specification allows for white to off-white appearance, agglomerated material may exhibit a slight yellowing due to localized oxidative stress. This does not necessarily indicate a purity drop, but it can be a visual cue for procurement teams to inspect the shipment. Our batch-specific COA includes a visual inspection note, and we advise customers to document any deviation upon receipt. For critical applications, such as the synthesis of pharmaceutical-grade peptides, we can provide material with a whiteness index guarantee upon request.

Re-Slurrying Protocols Using Anhydrous DMF and Controlled Warming to Restore Flowability Without Hydrolysis

When winter agglomeration occurs, the material can be restored to its original free-flowing state through a validated re-slurrying procedure. This protocol has been developed by our process chemists to avoid hydrolysis of the Boc protecting group, which is acid-labile but can also be cleaved under prolonged exposure to moisture at elevated temperatures. The key is to use anhydrous DMF (water content < 50 ppm) and controlled warming under an inert atmosphere.

Step 1: Transfer the agglomerated N-Boc-D-cyclohexylglycinol into a dry reactor under nitrogen purge. Add anhydrous DMF (5–10 volumes based on the weight of the solid) and stir gently at 20–25°C. Avoid vigorous agitation to prevent mechanical stress on the crystals.

Step 2: Slowly warm the slurry to 30–35°C over 30 minutes. This temperature range is sufficient to break the weak interparticle forces without inducing Boc deprotection. Monitor the slurry consistency; the lumps should gradually disintegrate into a uniform suspension.

Step 3: Cool the slurry back to 20°C and filter under nitrogen pressure through a 10-micron filter cloth. Wash the filter cake with cold (0–5°C) anhydrous MTBE to displace residual DMF. Dry the solid under vacuum at 25–30°C for 12 hours or until constant weight.

The recovered material typically shows identical HPLC purity and chiral integrity compared to the original lot. However, it is essential to perform a full QC analysis before reuse in regulated processes. This re-slurrying method is particularly effective for Boc-D-Chg-ol because the compound has limited solubility in cold DMF, minimizing yield loss. For large-scale operations, this protocol can be adapted to a filter-dryer setup, reducing manual handling.

Bulk Packaging, Hazmat Classification, and Lead Time Optimization for N-Boc-D-cyclohexylglycinol Supply Chains

Efficient supply chain management for N-Boc-D-cyclohexylglycinol hinges on understanding its regulatory classification and packaging options. The compound is not classified as hazardous under DOT, IATA, or IMDG codes, which simplifies shipping and reduces freight costs. However, as a fine organic powder, it may be subject to dust explosion risks if handled improperly; our SDS recommends grounding and bonding during transfer operations.

For bulk procurement, we offer three standard packaging configurations:

• 25kg fiber drum: Ideal for R&D and pilot-scale campaigns. Double-lined with LDPE and desiccant. Gross weight approx. 28kg.
• 50kg fiber drum: For mid-scale production, with same lining specifications.
• 500kg IBC tote: For commercial manufacturing, with nitrogen headspace and optional temperature-controlled shipping.

Lead times for standard grades are typically 4–6 weeks from order confirmation, but winter shipments may require an additional 2 weeks for cold-chain logistics arrangements. We maintain safety stock of key intermediates at our Ningbo facility to buffer against seasonal demand spikes. For customers requiring just-in-time delivery, we can coordinate with regional warehouses in Europe and North America, though local storage conditions must be validated to prevent agglomeration.

To integrate this building block into your peptide synthesis workflow, explore our product page for detailed specifications: N-Boc-D-cyclohexylglycinol chiral synthesis intermediate grade.

Frequently Asked Questions

What are the optimal drum storage conditions for N-Boc-D-cyclohexylglycinol to prevent agglomeration?

Store sealed drums in a cool, dry area at 2–8°C. Avoid temperature fluctuations and protect from moisture. If cold storage is unavailable, a desiccated cabinet at ≤25°C is acceptable for short-term storage, but the material should be used within 6 months. Always replace the desiccant after opening.

What moisture barrier requirements are needed for 25kg packaging during ocean freight?

Our standard 25kg fiber drum includes a double LDPE liner and a silica gel desiccant bag (500g). For ocean freight during summer or through tropical zones, we recommend upgrading to vacuum-sealed aluminum foil bags inside the drum. This provides an absolute moisture barrier and prevents caking even under high humidity conditions.

How do lead times adjust for cold-chain logistics in winter?

Cold-chain shipments require an additional 7–14 days for arranging temperature-controlled containers and validating the logistics route. We advise placing orders by early October for delivery before the peak winter season. For urgent orders, we can use active temperature-controlled air freight, though this increases shipping costs by approximately 30%.

Can agglomerated N-Boc-D-cyclohexylglycinol be used directly in solid-phase synthesis?

It is not recommended. Agglomerated material should be re-slurried as per our protocol to ensure accurate weighing and consistent dissolution. Direct use may lead to resin loading variability and potential reactor fouling.

Is N-Boc-D-cyclohexylglycinol hygroscopic?

Yes, it is moderately hygroscopic. Prolonged exposure to ambient air can lead to moisture uptake of up to 2% by weight, which promotes agglomeration. Always handle under nitrogen or dry air, and reseal containers immediately after use.

Sourcing and Technical Support

As a global manufacturer of pharmaceutical-grade chiral intermediates, NINGBO INNO PHARMCHEM CO.,LTD. ensures that every batch of N-Boc-D-cyclohexylglycinol meets stringent quality standards for peptide synthesis and beyond. Our technical team is equipped to support your process development with custom packaging, stability studies, and logistics planning to overcome seasonal challenges. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.